Chairmen Welcome

ICTHIC Presentation and Welcome

Dear Colleagues,

We are pleased to invite you to ICTHIC, the high-level scientific conference dedicated to the critical interaction between thrombosis, hemostasis, and cancer.

Since its first edition in 2001, ICTHIC has provided an important forum to convene in the splendid medieval city of Bergamo, Italy. This biennial event, renowned for its elevated scientific quality and collaborative atmosphere, brings together the world's leading experts, researchers, clinicians, nurses and patients to explore the latest discoveries, current challenges, and prospects in this rapidly evolving field.

The connection between thrombosis and cancer has been recognized since the 19^th century, but the field has seen significant growth in recent decades. Venous thromboembolism (VTE), a frequent complication in cancer patients, particularly during cancer treatment, negatively impacts the course and prognosis of malignant disease.Management is complex: these patients are more prone to thrombotic recurrences or bleeding complications during anticoagulant treatments, making it crucial to find an effective therapeutic balance.

ICTHIC aims to explore the most relevant aspects of coagulation derangement associated with cancer, from pathophysiological mechanisms to prevention, diagnosis, and treatment strategies.

The ultimate goal is to reduce the burden and consequences of cancer-associated thrombosis and hemorrhage, improve patient quality of life and management, and ease the burden on the healthcare system. ICTHIC explores the past, present, and future of this field, within a constantly evolving framework of research and medical progress.

The Conference chairmen